Clincosm LogoSign in Get a demo

SARS-CoV-2 Infection

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

SARS-CoV-2 Infection Trial in United States (Moderna COVID-19 Vaccine)

Completed
  • SARS-CoV-2 Infection
  • Moderna COVID-19 Vaccine
  • Birmingham, Alabama
  • +50 more
Dec 1, 2022

SARS-CoV-2 Infection, Acute Kidney Injury Trial in New York, San Antonio, Seattle (Placebo, Nicotinamide riboside)

Active, not recruiting
  • SARS-CoV-2 Infection
  • Acute Kidney Injury
  • Placebo
  • Nicotinamide riboside
  • New York, New York
  • +3 more
Oct 25, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

COVID-19 Vaccination and Breakthrough Infections Among Persons

Completed
  • Immunocompromised
  • +5 more
  • BNT162b2 (Tozinameran)
  • New York, New York
    Pfizer Inc.
Jul 1, 2022

COVID on Children and Families

Recruiting
  • SARS-CoV-2 Infection
    • Birmingham, Alabama
    • +64 more
    May 5, 2022

    SARS-CoV-2 Infection Trial in New York, Rio De Janeiro (Convalescent Plasma (anti-SARS-CoV-2 plasma), Non-convalescent Plasma

    Completed
    • SARS-CoV-2 Infection
    • Convalescent Plasma (anti-SARS-CoV-2 plasma)
    • Non-convalescent Plasma (control plasma)
    • New York, New York
    • +3 more
    May 16, 2021